{
    "clinical_study": {
        "@rank": "46858", 
        "arm_group": [
            {
                "arm_group_label": "Active supplement", 
                "arm_group_type": "Active Comparator", 
                "description": "NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin\u00ae (40 mg) and the proprietary blend (900mg)."
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The placebo is identical in appearance to the NutraStem\u00ae supplement and contains the following ingredients in a Vegi Capsule:\nMCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if an investigational supplement called NutraStem\u00ae will\n      increase the amount of stem cells in human blood at rest and after exercise.  The\n      ingredients found in NutraStem\u00ae can be found in nutrition or vitamin shops/stores."
        }, 
        "brief_title": "Exercise and NutraStem (NT-020): Effects on Stem Cells", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Adult Stem Cell Proliferation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy men and women\n\n          -  Age 50 to 70 years old\n\n          -  Ability to walk on a treadmill for 15 minutes.\n\n        Exclusion Criteria:\n\n          -  Age less than 50 or greater than 70 years of age.\n\n          -  A history of difficult veins/difficulty obtaining blood samples\n\n          -  Unwilling to follow the procedures of the trial\n\n          -  Participated in more than 2 sessions per week of strenuous exercise in the last month\n\n          -  Unable to tolerate the ingredients in NutraStem\u00ae or placebo, or have food allergies\n\n          -  Intentionally lost or gained 10 or more pounds of body weight in the last 3 months\n\n          -  Acute illness\n\n          -  Severe co-morbid disease\n\n          -  Use of any prescription or non-prescription products for antioxidant regimen or stem\n             cell supplement within the past 4 weeks\n\n          -  Diabetic\n\n          -  Uncontrolled hypertension\n\n          -  Recent cardiovascular event (past 36 months), or a family history of sudden death or\n             heart attacks before the age of 55\n\n          -  Body Mass Index (BMI) of less than 20 or greater than 35 m/kg2;\n\n          -  Participated in a clinical trial in the past 4 weeks\n\n          -  Take methadone, insulin, anticoagulants (blood thinners), MAO's or similar\n             medications\n\n          -  Anticipate the need for surgery of any type during the entire study;\n\n          -  Plan to donate blood or blood products during the study or for thirty (30) days\n             following the study\n\n          -  Active peptic ulcer disease or reliable history of gastrointestinal bleeding within\n             the past five (5) years\n\n          -  Recurrent or a history of intestinal disorders that may interfere with the absorption\n             of the product\n\n          -  Any disease or condition that in the investigator's opinion compromises the integrity\n             of the clinical trial or the safety of the subject"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847027", 
            "org_study_id": "2012-162"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active supplement", 
                "intervention_name": "NutraStem", 
                "intervention_type": "Drug", 
                "other_name": "NT-020"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Sugar pill"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Healthy", 
            "Stem cells", 
            "Aging", 
            "Increase stem cell replacement", 
            "decreased stem cell proliferation"
        ], 
        "lastchanged_date": "August 26, 2013", 
        "location": {
            "contact": {
                "email": "kim.brown@unthsc.edu", 
                "last_name": "Kim Brown, RN", 
                "phone": "817-735-2694"
            }, 
            "contact_backup": {
                "email": "meharvan.singh@unthsc.edu", 
                "last_name": "Meharvan Singh, PhD", 
                "phone": "817-735-5429"
            }, 
            "facility": {
                "address": {
                    "city": "Fort Worth", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "76107"
                }, 
                "name": "University of North Texas Health Science Center - Center for Biohealth"
            }, 
            "investigator": {
                "last_name": "Meharvan Singh, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 2 Study of the Effect of a Nutritional Supplement and Exercise on Human Stem Cells", 
        "overall_contact": {
            "email": "kim.brown@unthsc.edu", 
            "last_name": "Kim Brown, RN", 
            "phone": "817-735-2694"
        }, 
        "overall_contact_backup": {
            "email": "meharvan.singh@unthsc.edu", 
            "last_name": "Meharvan Singh, PhD", 
            "phone": "817-735-5429"
        }, 
        "overall_official": {
            "affiliation": "University of North Texas Health Science Center", 
            "last_name": "Meharvan Singh, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Increased stem cell proliferation in active supplement arm", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847027"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of North Texas Health Science Center", 
            "investigator_full_name": "Meharvan Singh", 
            "investigator_title": "Chairman and Professor, Department of Pharmacology and Neuroscience", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Markers of oxidative stress", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "University of North Texas Health Science Center", 
        "sponsors": {
            "collaborator": {
                "agency": "University of South Florida", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of North Texas Health Science Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}